article thumbnail

Florida's New BBL Safety Law Praised by Cosmetic Surgeons

MedEsthetics

Florida's new law mandating the use of ultrasound guidance during gluteal fat grafting procedures has been praised by the AACS and ABCS for implementing improved patient safety measures without limiting surgeons' right to practice.

Safety 147
article thumbnail

Deucravacitinib Demonstrates Sustained Efficacy and Safety in 4-Year Psoriasis Trial

Dermatology Times

Bristol Myers Squibb announced 70% of patients maintained significant improvement after 4 years with no new safety concerns.

Safety 74
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

4 Tips for Ensuring Spa Safety 

Spa Industry Association

Ignoring safety regulations and requirements can lead to severe health issues that can cause them to be held liable for any damages that occur. Continue reading 4 Tips for Ensuring Spa Safety at Spa Industry Association. Spa owners and managers must keep their customers and employees safe.

Safety 40
article thumbnail

Best Practices To Ensure Client and Employee Safety in Spas 

Spa Industry Association

Why Spa Safety Is Important Establishments that serve the public have to protect their customers and employees. Continue reading Best Practices To Ensure Client and Employee Safety in Spas at Spa Industry Association. Learn how to equip your spa to be a literal haven for your team and anyone who walks through its doors.

Safety 52
article thumbnail

Misuse of At-home Medical Devices Tops ECRI's List of Technology Safety Hazards

MedEsthetics

Safety hazards can develop when medical devices that are designed for use by healthcare professionals are too complex for typical patient use.

Safety 60
article thumbnail

Analyzing the Safety of JAK Inhibitors in Atopic Dermatitis Treatment

Dermatology Times

Ruth Ann Vleugels, MD, and Christopher Bunick, MD, agreed that the long-term safety data for JAK inhibitors makes them preferable to systemic steroids.

Safety 87
article thumbnail

Four-Year Data: Sotyktu Demonstrates Durable Response Rates, Consistent Safety in Moderate-to-Severe Plaque PsO

The Dermatology Digest

Deucravacitinib (Sotyktu, Bristol Myers Squibb) showed durable response rates and consistent safety in patients with moderate-to-severe plaque psoriasis after four years of continuous treatment, according to results from the POETYK PSO long-term extension (LTE) trial. patient-years (PYs) for the safety analyses. Year 4, 0.1)

Safety 36